분자 세포 유전학 시장 규모, 점유율, 성장 분석 : 제품별, 기술별, 용도별, 최종사용자별, 지역별 - 산업별 예측(2024-2031년)
Molecular Cytogenetics Market Size, Share, Growth Analysis, By Product (Kits & Reagents, Testing Kits), By Technique (Comparative Genomic Hybridization), By Application, By End User, By Region - Industry Forecast 2024-2031
상품코드:1619169
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2024년 12월
페이지 정보:영문 242 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 분자 세포 유전학 시장 규모는 2022년에 23억 7,000만 달러로 평가되며, 2023년 25억 8,000만 달러에서 2031년에는 50억 2,000만 달러로 성장하며, 예측 기간 중(2024-2031년)에 CAGR 8.7%로 성장할 전망입니다.
분자생물학과 세포 유전학을 통합한 분자 세포 유전학 분야는 정상적인 인간 세포에는 46개의 염색체가 존재한다는 기초 지식을 바탕으로 건강한 세포와 암세포를 구별하는 데 중요한 역할을 합니다. 이 분야는 형광 in situ hybridization(FISH)과 같은 기술을 통해 염색체 이상에 초점을 맞추고 뇌종양 및 혈액 악성 종양을 포함한 다양한 암을 감지하고 치료하는 데 도움을 줍니다. 이 시장은 암 유병률 증가, 유전성 질환, 고령화 등으로 인해 상당한 성장세를 보이고 있습니다. 또한 표적 치료의 보급과 시약 및 소프트웨어 개선을 포함한 의료 기술의 발전은 진단 정확도 향상에 기여하고 있습니다. 생물 의학 연구에 대한 투자 증가는 시장 확대를 더욱 촉진하고, 분자 세포 유전학의 탄탄한 미래를 예측했습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요의 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2023년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
기술의 진보
규제 상황
사례 연구
특허 분석
분자 세포 유전학 시장 규모 : 제품별
시장 개요
키트와 시약
검사 키트
프로브
형광 친화성 시약
기타 키트와 시약
기기
소모품
소프트웨어와 서비스
분자 세포 유전학 시장 규모 : 기술별
시장 개요
비교 게놈 하이브리다이제이션
어레이 기반 비교 게놈 하이브리다이제이션
표준 비교 게놈 하이브리다이제이션
형광 In-Situ 하이브리다이제이션
크로모제닉 In-Situ 하이브리다이제이션
핵형 분석
스펙트럼
가상
기타 테크닉
분자 세포 유전학 시장 규모 : 용도별
시장 개요
유전성 질환
암
맞춤형 의료
기타 용도
분자 세포 유전학 시장 규모 : 최종사용자별
시장 개요
임상 조사실
병원과 병리 검사실
학술 조사기관
제약·바이오테크놀러지 기업
기타 최종사용자
분자 세포 유전학 시장 규모 : 지역별
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2023년)
주요 시장 기업이 채택한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2023년)
주요 기업의 기업 개요
회사 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출의 전년대비 비교(2021-2023)
주요 기업 개요
F. Hoffmann-la roche ltd.
Agilent technologies, inc.
Abbott laboratories
Thermo fisher scientific, inc.
Illumina inc.
Revvity
Pacific biosciences
Bio-rad laboratories, inc.
Bio-techne corporation
Genedx
Bioview
Applied spectral imaging, inc.
Cytotest inc.
Kromatid, inc.
Genial genetic solutions ltd.
Cytognomix, inc.
Metasystems
Scigene
Biomodal
Biocare medical
결론과 권장사항
KSA
영문 목차
영문목차
Global Molecular Cytogenetics Market size was valued at USD 2.37 billion in 2022 and is poised to grow from USD 2.58 billion in 2023 to USD 5.02 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2024-2031).
The field of molecular cytogenetics, integrating molecular biology and cytogenetics, plays a crucial role in distinguishing healthy cells from cancerous ones, stemming from the foundational knowledge that normal human cells contain 46 chromosomes. This discipline aids in the detection and treatment of various cancers, including brain tumors and hematological malignancies, focusing on chromosomal abnormalities through techniques like fluorescence in situ hybridization (FISH). The market is witnessing significant growth, driven by the increasing prevalence of cancer, genetic disorders, and an aging population. Additionally, the rising adoption of targeted therapies and advancements in healthcare technology, including improved reagents and software, contribute to enhanced diagnostic accuracy. Increased investment in biomedical research further propels market expansion, projecting a robust future for molecular cytogenetics.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Molecular Cytogenetics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Molecular Cytogenetics Market Segmental Analysis
Global Molecular Cytogenetics Market is segmented by product, technique, application, end user and region. Based on product, the market is segmented into kits & reagents, instruments, consumables and software & services. Based on technique, the market is segmented into comparative genomic hybridization, fluorescence in-situ hybridization, chromogenic in-situ hybridization, karyotyping and other techniques. Based on application, the market is segmented into genetic disorders, cancer, personalized medicine and other applications. Based on end user, the market is segmented into clinical & research laboratories, hospitals & path labs, academic research institutes, pharmaceutical & biotechnology companies and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Molecular Cytogenetics Market
The Global Molecular Cytogenetics market is poised for significant growth, driven primarily by the rising incidence of cancer cases worldwide. This field, which merges the principles of cytogenetics with molecular biology, is expected to see increased adoption as more healthcare professionals recognize its efficacy in diagnosing and understanding various cancers. The growing prevalence of cancer not only highlights the need for advanced diagnostic tools but also encourages investments and research in molecular cytogenetics, thereby fueling market expansion. As a result, the demand for molecular cytogenetics will likely continue to rise throughout the projected period.
Restraints in the Global Molecular Cytogenetics Market
The Global Molecular Cytogenetics market faces several significant constraints that could impede its growth. Stringent regulatory requirements pose a challenge, as compliance can be both complex and time-consuming. Additionally, unfavorable reimbursement policies from insurance providers significantly limit access to molecular diagnostic tests, which are essential for early detection of genetic conditions. The high costs associated with these tests, typically ranging around USD 300 each, also create a financial barrier for many patients and healthcare providers. Collectively, these factors contribute to a restrictive environment that hampers the expansion of the molecular cytogenetics market.
Market Trends of the Global Molecular Cytogenetics Market
The Global Molecular Cytogenetics market is witnessing a robust growth trend, driven primarily by the increasing emphasis on personalized medicine and advanced therapeutic options in oncology. As genomic understanding becomes crucial for effective cancer care-enabling precise diagnostics, tailored treatment plans, and improved survival predictions-the demand for molecular cytogenetic techniques is surging. This market is expected to expand significantly as healthcare providers leverage these technologies for detailed cancer analysis and individualized therapies. As pharmacotherapy and bespoke treatment alternatives gain prominence, the market is poised for lucrative expansion throughout the forecast period, underlining the pivotal role of molecular cytogenetics in modern oncology.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies
Patent Analysis
Global Molecular Cytogenetics Market Size by Product & CAGR (2024-2031)
Market Overview
Kits & Reagents
Testing Kits
Probes
Fluorescent Affinity Reagents
Other Kits & Reagents
Instruments
Consumables
Software & Services
Global Molecular Cytogenetics Market Size by Technique & CAGR (2024-2031)
Market Overview
Comparative Genomic Hybridization
Array-Based Comparative Genomic Hybridization
Standard Comparative Genomic Hybridization
Fluorescence In-Situ Hybridization
Chromogenic In-Situ Hybridization
Karyotyping
Spectral
Virtual
Other Techniques
Global Molecular Cytogenetics Market Size by Application & CAGR (2024-2031)
Market Overview
Genetic Disorders
Cancer
Personalized Medicine
Other Applications
Global Molecular Cytogenetics Market Size by End User & CAGR (2024-2031)
Market Overview
Clinical & Research Laboratories
Hospitals & Path Labs
Academic Research Institutes
Pharmaceutical & Biotechnology Companies
Other End Users
Global Molecular Cytogenetics Market Size & CAGR (2024-2031)
North America (Product, Technique, Application, End User)
USA
Canada
Europe (Product, Technique, Application, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product, Technique, Application, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product, Technique, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Product, Technique, Application, End User)
